Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A screenshot of the coronavirus grown in a lab in Australia. Photo: Doherty Institute

Scientists in Melbourne, Australia, have become the first to re-create the Wuhan coronavirus outside of China.

Why it matters: It's a "significant breakthrough," which will enable accurate investigation and diagnosis of the virus globally, per a statement by the Doherty Institute released Tuesday morning (ET). It's hoped it will help efforts to treat the virus.

  • Mike Catton, deputy director of the Doherty Institute, said at a news conference on Wednesday, "The virus can be used in the assessment of the effectiveness of vaccines particularly and of medicines."
"It also gives us the opportunity to create a first-generation antibody test, and that's important both in the clinical management of patients who may be late in the illness ... and it's also really important for us to look at things like asymptomatic infection with the virus or mild infection that hasn't come to the attention of health authorities, and those patients haven't been tested and identified as cases."

The big picture: Officials in China released the genome sequence of this novel coronavirus, "which is helpful for diagnosis," notes Royal Melbourne Hospital's Julian Druce, the head of the virus identification laboratory at the Doherty Institute, in the statement.

  • But "having the real virus means we now have the ability to actually validate and verify all test methods, and compare their sensitivities and specificities," Druce said.
[I]t will be a game-changer for diagnosis."
— Julian Druce statement

What they did: Scientists grew the virus from a patient sample at the Doherty Institute on Jan. 24.

What's next: The virus will be shipped to scientists at expert laboratories who are working closely with the World Health Organization in Europe, and it will be used in Australian public health labs as "positive control material," Druce said.

  • The Doherty Institute-grown virus is expected to be used to generate an antibody test, which allows detection of the virus in patients who haven't displayed symptoms and were therefore unaware they had the virus, according to Catton.
  • "An antibody test will enable us to retrospectively test suspected patients so we can gather a more accurate picture of how widespread the virus is, and consequently, among other things, the true mortality rate," Catton said in a statement.
  • "It will also assist in the assessment of effectiveness of trial vaccines."

Go deeper: What's happening with the coronavirus

Editor's note: This article has been updated with Catton's press conference comments.

Go deeper

Biden taps Brian Deese to lead National Economic Council

Brian Deese (L) in 2015 with special envoy for climate change Todd Stern (C) and Secretary of State John Kerry (R). Photo: Mandel Ngan/AFP via Getty Images

President-elect Joe Biden announced Thursday that he has selected Brian Deese, a former Obama climate aide and head of sustainable investing at BlackRock, to serve as director of the National Economic Council.

Why it matters: The influential position does not require Senate confirmation, but Deese's time working for BlackRock, the world's largest asset manager and an investor in fossil fuels, has made him a target of criticism from progressives.

Felix Salmon, author of Capital
31 mins ago - Economy & Business

The places regulation does not reach

Illustration: Aïda Amer/Axios

Financial regulation is not exactly simple anywhere in the world. But one country stands out for the sheer amount of complexity and confusion in its regulatory regime — the U.S.

Why it matters: Important companies fall through the cracks, largely unregulated, while others contend with a vast array of regulatory bodies, none of which are remotely predictable.

1 hour ago - Economy & Business

Boeing gets huge 737 Max order from Ryanair, boosting hope for quick rebound

Ryanair low cost airline Boeing 737-800 aircraft as seen over the runway. Photo by Nik Oiko/SOPA Images/LightRocket via Getty Images

Dublin-based Ryanair said it would add 75 more planes to an existing order for Boeing's 737 Max airplanes, a giant vote of confidence as Boeing seeks to revive sales of its best-selling plane after a 20-month safety ban following two fatal crashes.

The big picture: Ryanair's big order, on the heels of breakthrough vaccine news, is also a promising sign that the devastated airline industry might recover from the global pandemic sooner than expected.